Russia Working to Align Biologics Regs with International Standards
Regulators and the drug industry met in Moscow last week to develop a framework for firms developing biologics and biosimilars in the Russian Federation.
Archives for May 19, 2013
Covance Pushes Further into Biologics Development, Lead Optimization
Although preclinical work for CROs has fallen flat in recent quarters, Covance is looking to take advantage of the industry’s shift to early biologic developments and lead optimization.